+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Humanized Mouse & Rat Model Market - Global Forecast 2026-2032- Product Image
Humanized Mouse & Rat Model Market - Global Forecast 2026-2032- Product Image
New

Humanized Mouse & Rat Model Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5847087
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The humanized mouse and rat model market is evolving rapidly, as advanced genetics and shifting operational priorities drive demand for highly translational in vivo solutions. Strategic model selection now critically determines translational reliability and operational continuity for biopharmaceutical pipelines.

Market Snapshot

The Humanized Mouse & Rat Model Market expanded from USD 297.24 million in 2025 to USD 317.57 million in 2026. With a compound annual growth rate (CAGR) of 7.54%, the market is poised to reach USD 494.48 million by 2032. Driven by the need for models that closely mirror human biology, its sustained growth reflects increasing integration of these platforms in discovery and preclinical development pipelines.

Scope & Segmentation

This report delivers a segmented analysis positioning market trends and procurement priorities across the following domains:

  • Model Types: Humanized rat models (including hACE2 and hCD4 subtypes), immunodeficient models (NOG, NSG, SCID), patient-derived xenograft (PDX) models for diverse tumor types, and transgenic knock-in/knock-out models.
  • Disease Applications: Oncology (hematological and solid tumors), immunology (autoimmune and inflammatory diseases), cardiovascular, infectious disease (viral and bacterial), and neurology (neurodegenerative and pain models).
  • End-User Needs: Academic institutes emphasize mechanistic fidelity, contract research organizations focus on throughput and documentation, and pharma/biotech sponsors prioritize regulatory readiness and vendor reliability.
  • Product-Service Combinations: Standardized commercial models, fully custom genetic and phenotypic constructs, and value-added services such as efficacy testing, model development, and screening services.
  • Regional Dynamics: Americas leverage integrated vendor ecosystems for rapid translational progress, Europe and Middle East & Africa focus on regulatory harmonization and cross-border collaboration, while Asia-Pacific drives cost efficiency and expands outsourcing platforms.
  • Technology Use: CRISPR-based genome engineering, advanced immunoediting, high-throughput phenotyping, and integration of multi-omics and in vivo imaging technologies.

Key Takeaways: Strategic Insights for the Humanized Mouse and Rat Model Market

  • Strategic deployment of humanized models is central to achieving reliable translational outcomes and mitigating operational risk.
  • Breakthroughs in genome engineering, immune system humanization, and phenotyping technology have increased model fidelity and confidence in predictive efficacy for complex therapeutics.
  • Procurement strategies now blend standardized off-the-shelf models for screening with custom-developed solutions for high-value programs to optimize speed, cost, and scientific integrity.
  • Tariff shifts and evolving trade policies are prompting reassessment of global and domestic sourcing, driving flexible supply chains and diversified vendor panels.
  • Supplier differentiation is now based on rigorous validation, integrated data delivery, and end-to-end service offerings that span discovery, translational testing, and regulatory documentation.
  • Effective model adoption requires cross-functional collaboration among discovery, translational, and procurement teams to reduce misalignment and accelerate study initiation.

Tariff Impact

Recent changes in trade policy have led to increased duties on specialized animal models and ancillary materials, creating new cost and lead-time dynamics. Organizations are responding with strategies such as expanding domestic sourcing, scenario planning, and capacity prioritization. These responses help build resilience in research timelines and safeguard critical projects from unexpected supply disruptions.

Methodology & Data Sources

This analysis employs mixed-methods research, integrating secondary reviews of scientific literature, regulatory guidance, and patent filings with structured interviews of industry and academic stakeholders. Cross-validation of findings against operational data ensures robust, actionable insights for strategic planning.

Why This Report Matters

  • Enables stakeholders to balance scientific rigor, speed, and cost in selecting humanized models for drug and diagnostic development.
  • Supports procurement and executive teams with segmentation-driven frameworks to align sourcing decisions with regulatory and operational goals.
  • Informs investment and partnership strategies by outlining technological advancements and regional market strengths that impact translational success.

Conclusion

Humanized mouse and rat models are foundational to advancing translational programs for the biopharmaceutical industry. Leaders who align model selection, supplier diversity, and internal capabilities will be best positioned to drive program success and organizational resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Humanized Mouse & Rat Model Market, by Model Type
8.1. Humanized Rat Models
8.1.1. hACE2 Rat Models
8.1.2. hCD4 Rat Models
8.2. Immunodeficient Models
8.2.1. NOG Models
8.2.2. NSG Models
8.2.3. SCID Models
8.3. PDX Models
8.3.1. Breast Cancer PDX
8.3.2. Colorectal Cancer PDX
8.3.3. Lung Cancer PDX
8.4. Transgenic Models
8.4.1. Knock-In Models
8.4.2. Knock-Out Models
9. Humanized Mouse & Rat Model Market, by Application
9.1. Cardiovascular
9.1.1. Atherosclerosis Models
9.1.2. Hypertension Models
9.2. Immunology
9.2.1. Autoimmune Disorder Models
9.2.2. Inflammatory Disease Models
9.3. Infectious Disease
9.3.1. Bacterial Infection Models
9.3.2. Viral Infection Models
9.4. Oncology
9.5. Cell Therapy Testing
10. Humanized Mouse & Rat Model Market, by End User
10.1. Academic Research Institutes
10.2. Contract Research Organizations
10.3. Pharmaceutical Biotech Companies
11. Humanized Mouse & Rat Model Market, by Human Cell
11.1. CD34+ Stem Cells
11.2. PBMC
11.3. Patient Tumor Tissue (PDX)
11.4. iPSC-derived Cells
12. Humanized Mouse & Rat Model Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Humanized Mouse & Rat Model Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Humanized Mouse & Rat Model Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Humanized Mouse & Rat Model Market
16. China Humanized Mouse & Rat Model Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Aragen Life Sciences Ltd.
17.6. Biocytogen
17.7. Champions Oncology, Inc.
17.8. Charles River Laboratories
17.9. Crown Biosciences
17.10. Cyagen Biosciences
17.11. GemPharmatech
17.12. genOway
17.13. Harbour BioMed
17.14. Hera BioLabs
17.15. Ingenious Targeting Laboratory
17.16. Inotiv
17.17. Oncodesign Services
17.18. Ozgene Pty Ltd.
17.19. Pharmatest Services
17.20. Taconic Biosciences, Inc.
17.21. The Jackson Laboratory
17.22. TRANS GENIC
17.23. TransCure bioServices
17.24. Vitalstar Biotechnology
List of Figures
FIGURE 1. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HACE2 RAT MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HACE2 RAT MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HACE2 RAT MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HCD4 RAT MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HCD4 RAT MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HCD4 RAT MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NOG MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NOG MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NOG MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NSG MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NSG MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY NSG MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SCID MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SCID MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SCID MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BREAST CANCER PDX, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BREAST CANCER PDX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BREAST CANCER PDX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COLORECTAL CANCER PDX, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COLORECTAL CANCER PDX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COLORECTAL CANCER PDX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY LUNG CANCER PDX, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY LUNG CANCER PDX, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY LUNG CANCER PDX, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY KNOCK-IN MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY KNOCK-IN MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY KNOCK-IN MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY KNOCK-OUT MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY KNOCK-OUT MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY KNOCK-OUT MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ATHEROSCLEROSIS MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ATHEROSCLEROSIS MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ATHEROSCLEROSIS MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HYPERTENSION MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HYPERTENSION MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HYPERTENSION MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY AUTOIMMUNE DISORDER MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY AUTOIMMUNE DISORDER MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY AUTOIMMUNE DISORDER MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFLAMMATORY DISEASE MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFLAMMATORY DISEASE MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFLAMMATORY DISEASE MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BACTERIAL INFECTION MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BACTERIAL INFECTION MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY BACTERIAL INFECTION MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY VIRAL INFECTION MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY VIRAL INFECTION MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY VIRAL INFECTION MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CELL THERAPY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CELL THERAPY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CELL THERAPY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PHARMACEUTICAL BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CD34+ STEM CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CD34+ STEM CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CD34+ STEM CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PBMC, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PBMC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PBMC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PATIENT TUMOR TISSUE (PDX), BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PATIENT TUMOR TISSUE (PDX), BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PATIENT TUMOR TISSUE (PDX), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IPSC-DERIVED CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IPSC-DERIVED CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IPSC-DERIVED CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 158. EUROPE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. EUROPE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 160. EUROPE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 161. EUROPE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 162. EUROPE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. EUROPE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 166. EUROPE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. EUROPE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 168. EUROPE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. EUROPE HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 182. AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 184. AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 185. AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 186. AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 187. AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 188. AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 190. AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 191. AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 192. AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. AFRICA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 207. ASEAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. ASEAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 209. ASEAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 210. ASEAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 211. ASEAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 212. ASEAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 213. ASEAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. ASEAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 215. ASEAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 216. ASEAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 217. ASEAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. ASEAN HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 219. GCC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. GCC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 221. GCC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 222. GCC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 223. GCC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 224. GCC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 225. GCC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. GCC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 227. GCC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 228. GCC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 229. GCC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 230. GCC HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 243. BRICS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. BRICS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 245. BRICS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 246. BRICS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 247. BRICS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 248. BRICS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 249. BRICS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 250. BRICS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 251. BRICS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 252. BRICS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 253. BRICS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. BRICS HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 255. G7 HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. G7 HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 257. G7 HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 258. G7 HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 259. G7 HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 260. G7 HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 261. G7 HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 262. G7 HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 263. G7 HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 264. G7 HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 265. G7 HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. G7 HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 267. NATO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. NATO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 269. NATO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 270. NATO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 271. NATO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 272. NATO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 273. NATO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 274. NATO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 275. NATO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 276. NATO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 277. NATO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. NATO HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 279. GLOBAL HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)
TABLE 292. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 293. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY MODEL TYPE, 2018-2032 (USD MILLION)
TABLE 294. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMANIZED RAT MODELS, 2018-2032 (USD MILLION)
TABLE 295. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNODEFICIENT MODELS, 2018-2032 (USD MILLION)
TABLE 296. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY PDX MODELS, 2018-2032 (USD MILLION)
TABLE 297. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY TRANSGENIC MODELS, 2018-2032 (USD MILLION)
TABLE 298. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 299. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 300. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 301. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 302. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 303. CHINA HUMANIZED MOUSE & RAT MODEL MARKET SIZE, BY HUMAN CELL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Humanized Mouse & Rat Model market report include:
  • Aragen Life Sciences Ltd.
  • Biocytogen
  • Champions Oncology, Inc.
  • Charles River Laboratories
  • Crown Biosciences
  • Cyagen Biosciences
  • GemPharmatech
  • genOway
  • Harbour BioMed
  • Hera BioLabs
  • Ingenious Targeting Laboratory
  • Inotiv
  • Oncodesign Services
  • Ozgene Pty Ltd.
  • Pharmatest Services
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • TRANS GENIC
  • TransCure bioServices
  • Vitalstar Biotechnology

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 317.57 Million
Forecasted Market Value ( USD ) by 2032 $ 494.48 Million
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Humanized Mouse and Rat Model Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Humanized Mouse and Rat Model Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Rat Model Market Report 2025 - Product Image

Rat Model Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Humanized Mouse and Rat Model - Global Strategic Business Report - Product Image

Humanized Mouse and Rat Model - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Humanized Mouse and Rat Model Market by Type, Application, End User, and Region - Global Forecast to 2030 - Product Image

Humanized Mouse and Rat Model Market by Type, Application, End User, and Region - Global Forecast to 2030

  • Report
  • 255 Pages
  • Global
From
Rat Model - Global Strategic Business Report - Product Image

Rat Model - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.